Recent contributions of in vitro models to our understanding of hepatitis C virus life cycle.
Hepatitis C virus is a human pathogen responsible for liver diseases including acute and chronic hepatitis, cirrhosis and hepatocellular carcinoma. Its high prevalence, the absence of a prophylactic vaccine and the poor efficiency of current therapies are huge medical problems. Since the discovery of the hepatitis C virus, our knowledge of its biology has been largely punctuated by the development of original models of research. At the end of the 1980s, the chimpanzee model led to cloning of the viral genome and the definition of infectious molecular clones. In 1999, a breakthrough was achieved with the development of a robust in vitro replication model named 'replicon'. This system allowed intensive research into replication mechanisms and drug discovery. Later, in 2003, pseudotyped retroviruses harbouring surface proteins of hepatitis C virus were produced to specifically investigate the viral entry process. It was only in 2005 that infectious viruses were produced in vitro, enabling intensive investigations into the entire life cycle of the hepatitis C virus. This review describes the different in vitro models developed to study hepatitis C virus, their contribution to current knowledge of the virus biology and their future research applications.
Régeard
Morgane
M
INSERM, U522, IFR 140, Hôpital de Pontchaillou, Rennes, France.
Lepère
Charlotte
C
Trotard
Maud
M
Gripon
Philippe
P
Le Seyec
Jacques
J
D000818:Animals; D016174:Hepacivirus / Q000235:genetics / Q000502:physiology*; D006526:Hepatitis C / Q000821:virology*; D006801:Humans; D008954:Models, Biological; D012093:Replicon / Q000235:genetics; D014771:Virion / Q000502:physiology; D014779:Virus Replication / Q000502:physiology